REG - Itaconix PLC - Appointment of Joint Corporate Broker

ItaconixAnnouncement

25/04/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230425:nRSY2931Xa&default-theme=true

RNS Number : 2931X  Itaconix PLC  25 April 2023

25 April
2023
 

 

Itaconix plc

("Itaconix" or "the Company")

 

Appointment of Joint Corporate Broker

 

Itaconix plc, a leading innovator in sustainable plant-based polymers used to
decarbonise everyday consumer products, is pleased to announce the appointment
of Canaccord Genuity Limited as joint corporate broker, to work alongside
finnCap, with immediate effect.

 

- Ends -

 

 

For further information please contact:

 Itaconix plc                                                      +1 603 775 4400
 John R. Shaw / Laura Denner
 Belvedere Communications                                          +44 (0) 20 3008 6864
 John West / Llew Angus
 finnCap                                                           +44 (0) 20 7220 0500
 Nominated Adviser & Joint Broker

 Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

 Andrew Burdis / Sunila de Silva (ECM)
 Canaccord Genuity                                                 +44 (0) 20 7523 8000

 Joint Broker

 Adam James / Patrick Dolaghan

www.itaconix.com (http://www.itaconix.com)

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to
produce and sell specialty ingredients that improve the safety, performance,
and sustainability of consumer products.  The Company's current ingredients
are enabling and leading new generations of products in cleaning, hygiene, and
beauty.  Itaconix's contributions to the global low carbon economy are
recognised by the London Stock Exchange's Green Economy Mark.

https://itaconix.com/ (https://itaconix.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPEAELLAFSDEAA